Sagar Lonial
Fortuna: 5 M $ al 30/06/2026
Fortuna: 5 M $ al 30/06/2026
Dr. Sagar Lonial, MD, is an Independent Director at TG Therapeutics, Inc., a Chief Medical Officer at Winship Cancer Institute and a Department Chair-Hematology & Medical Oncology at Emory University School of Medicine.
He is on the Board of Directors at TG Therapeutics, Inc. He received his doctorate degree from the University of Louisville School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TG THERAPEUTICS, INC. 0,06 % | 11/06/2026 | 94.061 ( 0,06 % ) | 5 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TG THERAPEUTICS, INC. | Director/Miembro de la Junta | 29/04/2020 |
Winship Cancer Institute | Director Técnico/Científico/I+D | - |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
TG Therapeutics, Inc.
TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Louisville School of Medicine
University of Louisville School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Winship Cancer Institute |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.